Immunology and Allergy

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


1802 publications

En préparation
Uniting Machine Intelligence, Brain and Behavioural Sciences to Assist Criminal Justice.
Chén Oliver Y.
[URN][serval:BIB_D2B7729FCF9B]
In press
 
Deciphering factors linked with reduced SARS-CoV-2 susceptibility in the Swiss HIV Cohort Study.
Abela I.A., Hauser A., Schwarzmüller M., Pasin C., Kusejko K., Epp S., Cavassini M., Battegay M., Rauch A., Calmy A. et al. The Journal of infectious diseases. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F53FC91CC440]
2024
 
The characterization of CD8+ T-cell responses in COVID-19.
Yang Y., Miller H., Byazrova M.G., Cndotti F., Benlagha K., Camara NOS, Shi J., Forsman H., Lee P., Yang L. et al., 2024/12. Emerging microbes & infections, 13 (1) p. 2287118. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C213415EB1A6]
 
Strategies to target the central nervous system HIV reservoir.
Mastrangelo A., Gama L., Cinque P., 2024/05/01. Current opinion in HIV and AIDS, 19 (3) pp. 133-140. Peer-reviewed.
[DOI][Pmid][serval:BIB_2BAE3F1895BB]
 
The multifaceted nature of HIV tissue reservoirs.
Banga R., Perreau M., 2024/05/01. Current opinion in HIV and AIDS, 19 (3) pp. 116-123. Peer-reviewed.
[DOI][Pmid][serval:BIB_41BEE245D401]
 
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma.
Joo V., Abdelhamid K., Noto A., Latifyan S., Martina F., Daoudlarian D., De Micheli R., Pruijm M., Peters S., Hullin R. et al., 2024/04/30. Nature communications, 15 (1) p. 3664. Peer-reviewed.
[DOI][Pmid][serval:BIB_4D3A2A46F635]
Mental health and burnout during medical school: Longitudinal evolution and covariates
Carrard Valerie, Berney Sylvie, Bourquin Céline, Ranjbar Setareh, Castelao Enrique, Schlegel Katja, Gaume Jacques, Bart Pierre-Alexandre, Schmid Mast Marianne, Preisig Martin et al., 2024/04/16. PLOS ONE, 19 (4) pp. e0295100. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EE638253A8B9]
 
Vaccine Efficacy, Impact, Hesitancy, and Acceptance: Trends for Public Health.
Said E.A., Noto A., Cardinaud S., Al-Jabri A.A., 2024/04/11. Vaccines, 12 (4). Peer-reviewed.
[DOI][Pmid][serval:BIB_B3714DFC039F]
 
Comprendre les réactions d’hypersensibilité aux anticorps monoclonaux [Understanding hypersensitivity reactions to monoclonal antibodies]
Cattaneo V., Belkoniene M., Porret R., Harr T., Muller Y.D., 2024/04/03. Revue medicale suisse, 20 (868) pp. 705-710. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0EAD4399A1BF]
 
Fake news en médecine et leur impact sur nos patients. L’exemple de l’hydroxychloroquine.
Ribi C., 2024/04/03. Revue medicale suisse, 20 (868) pp. 679-680. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_FD40C04EE551]
 
La connectivite mixte et sa prise en charge [Mixed connective tissue disease and its management]
Curraj E., Belkoniene M., Keutchakeu-Tchatcho C., Ringwald M., Ribi C., 2024/04/03. Revue medicale suisse, 20 (868) pp. 699-704. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F3EAB7D18540]
 
Sarcoïdose cardiaque : un défi diagnostique et thérapeutique [Cardiac sarcoidosis: a diagnostic and therapeutic challenge]
Ammann S., Dominati A., Meyer P., Pruvot E., Ribi C., Seebach J., 2024/04/03. Revue medicale suisse, 20 (868) pp. 682-687. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EFA8F7C80D0B]
 
Thérapie cellulaire CAR-T dans le traitement des maladies auto-immunes [CAR-T therapy for autoimmune diseases]
Alcaraz-Serna A., Porret R., Trueb L., Ribi C., Seebach J., Muller Y.D., 2024/04/03. Revue medicale suisse, 20 (868) pp. 688-693. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_FC7F901BBC55]
 
Die Bedeutung des QuantiFERON Gold Plus-Tests für die Diagnose der vermuteten Augentuberkulose [The Importance of QuantiFERON Gold Plus Test for the Diagnosis of Presumed Ocular Tuberculosis]
Bruzzone F., Plebani M., Koryllou A., Perreau M., Guex-Crosier Y., 2024/04. Klinische Monatsblatter fur Augenheilkunde, 241 (4) pp. 432-434. Peer-reviewed.
[DOI][Pmid][serval:BIB_E61763DE6E63]
 
Distinct leukocyte populations and cytokine secretion profiles define tumoral and peritumoral areas in renal cell carcinoma.
Borcinova M., Bartolini R., Foley L.K., Novak V., Taborska P., Stakheev D., Rataj M., Smrz D., Fialova M., Hacek J. et al., 2024/04. Translational oncology, 42 p. 101891. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B55655674776]
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series.
Vicino A., Hottinger A.F., Latifyan S., Boughdad S., Becce F., Prior J.O., Kuntzer T., Brouland J.P., Dunet V., Obeid M. et al., 2024/04. Journal of neurology, 271 (4) pp. 1947-1958. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_29F8761FAE12]
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.
Bassetti M., Giacobbe D.R., Agvald-Ohman C., Akova M., Alastruey-Izquierdo A., Arikan-Akdagli S., Azoulay E., Blot S., Cornely O.A., Cuenca-Estrella M. et al., 2024/04. Intensive care medicine, 50 (4) pp. 502-515. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6F8D4AD6C304]
 
Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies.
Shankar-Hari M., Calandra T., Soares M.P., Bauer M., Wiersinga W.J., Prescott H.C., Knight J.C., Baillie K.J., Bos LDJ, Derde LPG et al., 2024/04. The Lancet. Respiratory medicine, 12 (4) pp. 323-336. Peer-reviewed.
[DOI][Pmid][serval:BIB_774F5F5B62A7]
Residual Partial Least Squares Learning: Brain Cortical Thickness Simultaneously Predicts Eight Non-pairwise-correlated Behavioural and Disease Outcomes in Alzheimer's Disease.
Chén O.Y., Vũ D.T., Diaz C.S., Bodelet J.S., Phan H., Allali G., Nguyen V.D., Cao H., He X., Müller Y. et al., 2024/03/27..
[URN][DOI][Pmid][serval:BIB_3B332933DA5C]
 
Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis.
Gillard J., Suffiotti M., Brazda P., Venkatasubramanian P.B., Versteegen P., de Jonge M.I., Kelly D., Bibi S., Pinto M.V., Simonetti E. et al., 2024/03/08. Nature communications, 15 (1) p. 2133. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C91442BE52F4]
 
Alterations in glutamate, arginine, and energy metabolism characterize cerebrospinal fluid and plasma metabolome of persons with HIV-associated dementia.
Mastrangelo A., Scotti G.M., Manteiga J.G., Gisslén M., Price R.W., Bestetti A., Turrini F., Caccia R., Gorelik L., Morelli M.J. et al., 2024/03/01. AIDS, 38 (3) pp. 299-308. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E10D6B785AB6]
 
Therapeutic antibodies and alternative formats against SARS-CoV-2.
Winiger R.R., Perez L., 2024/03. Antiviral research, 223 p. 105820. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A112961BCF9C]
The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers.
Gasca-Capote C., Lian X., Gao C., Roseto I.C., Jiménez-León M.R., Gladkov G., Camacho-Sojo M.I., Pérez-Gómez A., Gallego I., Lopez-Cortes L.E. et al., 2024/02/20. The Journal of clinical investigation, 134 (8). Peer-reviewed.
[DOI][Pmid][serval:BIB_B3A795F338D3]
Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial.
Manuel O., Laager M., Hirzel C., Neofytos D., Walti L.N., Hoenger G., Binet I., Schnyder A., Stampf S., Koller M. et al., 2024/02/17. Clinical infectious diseases, 78 (2) pp. 312-323. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AA450EA2BB8A]
Myeloid-Derived Suppressor-like Cells as a Prognostic Marker in Critically Ill Patients: Insights from Experimental Endotoxemia and Intensive Care Patients.
Schrijver I.T., Herderschee J., Théroude C., Kritikos A., Leijte G., Le Roy D., Brochut M., Chiche J.D., Perreau M., Pantaleo G. et al., 2024/02/08. Cells, 13 (4). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AAE7B79746C8]
Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort.
Windirsch K., Jordan S., Becker M.O., Bruni C., Dobrota R., Elhai M., Garaiman I.A., Mihai C.M., Iudici M., Hasler P. et al., 2024/02/06. Swiss medical weekly, 154 p. 3630. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A434393F87C4]
A Bayesian functional approach to test models of life course epidemiology over continuous time.
Bodelet J., Potente C., Blanc G., Chumbley J., Imeri H., Hofer S., Harris K.M., Muniz-Terrera G., Shanahan M., 2024/02/01. International journal of epidemiology, 53 (1). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_57BB1671B649]
 
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database.
Lepri G., Bruni C., Tofani L., Moggi-Pignone A., Orlandi M., Tomassetti S., Hughes M., Del Galdo F., Irace R., Distler O. et al., 2024/01/30. Diagnostics, 14 (3). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C74266759675]
 
Immunologie: ce qui a changé en 2023 [Immunology: what's new in 2023]
Ringwald M., Ribi C., 2024/01/17. Revue medicale suisse, 20 (856-7) pp. 47-50. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_DF897A402A27]
 
A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies.
Moullan N., Asiago J., Stecco K., Hadi S., Albizem M., Tieu H., Hock B., Fenwick C., Lin K., Lengsfeld T. et al., 2024/01. Infectious diseases and therapy, 13 (1) pp. 173-187. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_890F055350A3]
 
COVID-19 booster vaccine acceptance following allergy evaluation in individuals with allergies.
Stehlin F., Khoudja R.Y., Al-Otaibi I., ALMuhizi F., Fein M., Gilbert L., Tsoukas C., Ben-Shoshan M., Copaescu A.M., Isabwe GAC, 2024/01. The journal of allergy and clinical immunology. In practice, 12 (1) pp. 242-245.e2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F559B85F5530]
 
Editorial introductions
Pantaleo Giuseppe, Deeks Steven G., Alba Diana, 2024/01. Current Opinion in HIV and AIDS, 19 (1) pp. V-VI.
[DOI][WoS][serval:BIB_4BCD8844162A]
 
Extending Multiple Testing with Unknown Test Dependency via the CoCo Test: With Applications to Cancer Studies.
Gou Jiangtao, Wu Kai, Chén Oliver Y, 2024..
[serval:BIB_9F35DD74CF00]
High uptake of COVID-19 vaccines among healthcare workers in urban Uganda.
Kyakuwa N., Kimbugwe G., Nakanjako F., Kalute H., Mpooya S., Atuhairwe C., Perez L., Kikaire B., 2024. PloS one, 19 (4) pp. e0277072. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F48C46C29EC1]
Pre-transplant donor specific antibodies in ABO incompatible kidney transplantation - data from the Swiss transplant cohort study.
Deng Y., Frischnknecht L., Wehmeier C., de Rougemont O., Villard J., Ferrari-Lacraz S., Golshayan D., Gannagé M., Binet I., Wirthmueller U. et al., 2024. Frontiers in immunology, 15 p. 1355128. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DF8B8B7ED9A9]
Residual Partial Least Squares Learning: Brain Cortical Thickness Simultaneously Predicts Eight Non-pairwise-correlated Behavioural and Disease Outcomes in Alzheimer’s Disease
Chén Oliver Y, Vu Duy Thanh, Diaz Christelle Schneuwly, Bodelet Julien, Phan Huy, Allali Gilles, Nguyen Viet-Dung, Cao Hengyi, He Xingru, Muller Yannick et al., 2024..
[URN][DOI][serval:BIB_DE5854C92A82]
Risk factors for allergy documentation in electronic health record: A retrospective study in a tertiary health center in Switzerland.
Ringwald M., Moi L., Wetzel A., Comte D., Muller Y.D., Ribi C., 2024/01. Allergology international, 73 (1) pp. 143-150. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_931C991F3DB5]
 
The pathophysiology of sepsis and precision-medicine-based immunotherapy.
Giamarellos-Bourboulis E.J., Aschenbrenner A.C., Bauer M., Bock C., Calandra T., Gat-Viks I., Kyriazopoulou E., Lupse M., Monneret G., Pickkers P. et al., 2024/01. Nature immunology, 25 (1) pp. 19-28. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_06061B0B11B8]
2023
Statistical Quantile Learning for Large, Nonlinear, and Additive Latent Variable Models.
Bodelet Julien, Blanc Guillaume, Shan Jiajun, Terrera Graciela M., Chén Oliver Y, 2023/12/29..
[URN][DOI][serval:BIB_0622E4AB21A0]
Development of hybrid immunity during a period of high incidence of Omicron infections.
Frei A., Kaufmann M., Amati R., Butty Dettwiler A., von Wyl V., Annoni A.M., Vincentini J., Pellaton C., Pantaleo G., Fehr J.S. et al., 2023/12/25. International journal of epidemiology, 52 (6) pp. 1696-1707. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_58F5CD0974E9]
The Roles, Challenges, and Merits of the p Value.
Chén Oliver Y, Bodelet Julien S, Saraiva Raúl G, Phan Huy, Di Junrui, Nagels Guy, Schwantje Tom, Cao Hengyi, Gou Jiangtao, Reinen Jenna M et al., 2023/12/08. Patterns, 4 (12) p. 100878. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D084688E0A6D]
 
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study.
Bettiol A., Urban M.L., Padoan R., Groh M., Lopalco G., Egan A., Cottin V., Fraticelli P., Crimi C., Del Giacco S. et al., 2023/12. The Lancet. Rheumatology, 5 (12) pp. e707-e715. Peer-reviewed.
[DOI][Pmid][serval:BIB_24C3A2CB1959]
 
Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys.
Fenwick C., Turelli P., Duhoo Y., Lau K., Herate C., Marlin R., Lamrayah M., Campos J., Esteves-Leuenberger L., Farina A. et al., 2023/12. The Journal of infection, 87 (6) pp. 524-537. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0A69FF2015C1]
The role of dendritic cells in COVID-19 infection.
Wang X., Guan F., Miller H., Byazrova M.G., Cndotti F., Benlagha K., Camara NOS, Lei J., Filatov A., Liu C., 2023/12. Emerging microbes & infections, 12 (1) p. 2195019. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9405D2DA3A70]
 
Immunosuppresseurs et antécédent de cancer : quel risque de récidive?
Comte D., 2023/11/29. Revue medicale suisse, 19 (852) p. 2271. Peer-reviewed.
[URN][Pmid][serval:BIB_631A1993D9EF]
 
Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study.
Raineri A., Radtke T., Rueegg S., Haile S.R., Menges D., Ballouz T., Ulyte A., Fehr J., Cornejo D.L., Pantaleo G. et al., 2023/11/27. Nature communications, 14 (1) p. 7764. Peer-reviewed.
[DOI][Pmid][serval:BIB_BDC2C0B508CE]
 
Polyarteritis Nodosa: Old Disease, New Etiologies.
Wolff L., Horisberger A., Moi L., Karampetsou M.P., Comte D., 2023/11/23. International journal of molecular sciences, 24 (23). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BEEF8077D35B]
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023.
Ambrosioni J., Levi L., Alagaratnam J., Van Bremen K., Mastrangelo A., Waalewijn H., Molina J.M., Guaraldi G., Winston A., Boesecke C. et al., 2023/11. HIV medicine, 24 (11) pp. 1126-1136. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2C3981328BD1]
Novel targets for immune-checkpoint inhibition in cancer.
Borgeaud M., Sandoval J., Obeid M., Banna G., Michielin O., Addeo A., Friedlaender A., 2023/11. Cancer treatment reviews, 120 p. 102614. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FED5F30A54BE]
 
Worse cardiovascular and renal outcome in male SLE patients.
Mihailovic J., Ribi C., Chizzolini C., Trendelenburg M., Von Kempis J., Dahdal S., Huynh-Do U., Swiss Systemic Lupus Erythematosus Cohort Study Group (SSCS), 2023/10/30. Scientific reports, 13 (1) p. 18628. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6E0F97DEE154]
Lymph node dendritic cells harbor inducible replication-competent HIV despite years of suppressive ART.
Banga R., Procopio F.A., Lana E., Gladkov G.T., Roseto I., Parsons E.M., Lian X., Armani-Tourret M., Bellefroid M., Gao C. et al., 2023/10/11. Cell host & microbe, 31 (10) pp. 1714-1731.e9. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9F739E97B9B6]
Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses.
Ols S., Lenart K., Arcoverde Cerveira R., Miranda M.C., Brunette N., Kochmann J., Corcoran M., Skotheim R., Philomin A., Cagigi A. et al., 2023/10/10. Immunity, 56 (10) pp. 2425-2441.e14. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8E02FAD2D2CE]
Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines.
Alcaraz-Serna A., Noto A., Ermellino L., Monzambani-Banderet V., Tommasini F., Stehlin F., Girard C., Perreau M., Muller Y.D., 2023/10. Allergology international, 72 (4) pp. 600-603. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_58939F65DB86]
Correction to: New Dominant‑Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130‑Dependent Hyper‑IgE Syndrome.
Arlabosse T., Materna M., Riccio O., Schnider C., Angelini F., Perreau M., Rochat I., Superti-Furga A., Campos-Xavier B., Héritier S. et al., 2023/10. Journal of clinical immunology, 43 (7) p. 1674. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D920DAB3A125]
 
L-SeqSleepNet: Whole-cycle Long Sequence Modeling for Automatic Sleep Staging.
Phan H., Lorenzen K.P., Heremans E., Chén Oliver Y, Tran M.C., Koch P., Mertins A., Baumert M., Mikkelsen K.B., de Vos M., 2023/10. IEEE journal of biomedical and health informatics, 27 (10) pp. 4748-4757. Peer-reviewed.
[DOI][Pmid][serval:BIB_9BE4A24B8351]
 
New Dominant-Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130-Dependent Hyper-IgE Syndrome.
Arlabosse T., Materna M., Riccio O., Schnider C., Angelini F., Perreau M., Rochat I., Superti-Furga A., Campos-Xavier B., Héritier S. et al., 2023/10. Journal of clinical immunology, 43 (7) pp. 1566-1580. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BB16C2AE927C]
 
Myositis manifesting as respiratory insufficiency with anti-RNA polymerase III antibodies: an unusual presentation of graft-versus-host disease.
Wolff L., Clottu A., Mamez A.C., Ribi C., Grandoni F., 2023/09. Leukemia & lymphoma, 64 (9) pp. 1588-1591. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3D11BC441C65]
 
Pediatric Allergy and Immunology (PAI) is for polishing with artificial intelligence, but careful use.
Eigenmann P., Akenroye A., Atanaskovic Markovic M., Candotti F., Ebisawa M., Genuneit J., Kalayci Ö., Kollmann D., Leung ASY, Peters R.L. et al., 2023/09. Pediatric allergy and immunology, 34 (9) pp. e14023. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F053F1C1ECE1]
HIV specific Th1 responses are altered in Ugandans with HIV and Schistosoma mansoni coinfection.
Obuku A.E., Lugemwa J.K., Abaasa A., Joloba M., Ding S., Pollara J., Ferrari G., Harari A., Pantaleo G., Kaleebu P., 2023/08/29. BMC immunology, 24 (1) p. 25. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62C12F4E0858]
 
Relentless bilateral occlusive vasculitis in a patient with Crohn's disease treated with adalimumab after immunization with mRNA SARS-CoV-2 vaccine: a case report
Bughin Alice, Casanova Alex, Ribi Camillo, Guex-Crosier Yan, 2023/08/25..
[DOI][serval:BIB_DD232EBEFAC7]
PSTPIP1-Associated Myeloid-Related Proteinemia Inflammatory (PAMI) Syndrome: A Systematic Review.
Mejbri M., Renella R., Candotti F., Jaques C., Holzinger D., Hofer M., Theodoropoulou K., 2023/08/19. Genes, 14 (8) p. 1655. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E4AFB0AA68AA]
 
Insuffisance cardiaque aiguë comme présentation principale d'un syndrome catastrophique des antiphospholipides
Friedrich Bastien P., Burger Raphal, Alberio Lorenzo, Girod Grgoire, Kissling Sbastien, Grandoni Francesco, Graf Guillaume, Ribi Camillo, 2023/08/16. Forum Médical Suisse ‒ Swiss Medical Forum.
[DOI][serval:BIB_ADEB2BF23102]
 
Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine.
Mencarelli L., Moi L., Dewarrat N., Monti M., Alberio L., Ringwald M., Swierdzewska K., Panagiotis A., Ribi C., 2023/08/07. Vaccines, 11 (8) p. 1335. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6CE251741A8E]
 
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.
Lescoat A., Huang S., Carreira P.E., Siegert E., de Vries-Bouwstra J., Distler JHW, Smith V., Del Galdo F., Anic B., Damjanov N. et al., 2023/08/01. JAMA dermatology, 159 (8) pp. 837-847. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6D3F9BC1AB36]
Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients.
Fallet B., Foglierini M., Porret R., Alcaraz-Serna A., Sauvage C., Jenelten R., Caplanusi T., Gilliet M., Perez L., Fenwick C. et al., 2023/08. The Journal of infection, 87 (2) pp. 111-119. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9DA429039D3E]
 
Neoadjuvant Immunotherapy: A Promising New Standard of Care.
Boydell E., Sandoval J.L., Michielin O., Obeid M., Addeo A., Friedlaender A., 2023/07/24. International journal of molecular sciences, 24 (14) p. 11849. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EBC57E22479F]
The Statistical Analysis of the Varying Brain.
Chén Oliver Y., Thanh Vũ Duy, Greub Gilbert, Cao Hengyi, He Xingru, Muller Yannick, Petrovas Constantinos, Shou Haochang, Nguyen Viet-Dung, Zhi Bangdong et al., 2023/07/02. IEEE Statistical Signal Processing (SSP). Peer-reviewed.
[URN][DOI][WoS][serval:BIB_C6B3B6AA1F8B]
 
Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19.
Hocini H., Wiedemann A., Blengio F., Lefebvre C., Cervantes-Gonzalez M., Foucat E., Tisserand P., Surenaud M., Coléon S., Prague M. et al., 2023/07. Journal of clinical immunology, 43 (5) p. 894. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E5F153F4367A]
 
Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19.
Hocini H., Wiedemann A., Blengio F., Lefebvre C., Cervantes-Gonzalez M., Foucat E., Tisserand P., Surenaud M., Coléon S., Prague M. et al., 2023/07. Journal of clinical immunology, 43 (5) pp. 882-893. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_30D621CDC238]
A scalable workflow to test “shock and kill” therapeutic approaches against the HIV-1 latent reservoir in blood cells ex vivo
Procopio Francesco Andrea, Savarino Andrea, Shytaj Iart Luca, 2023/06. STAR Protocols, 4 (2) p. 102253. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2DD4D5126887]
A severe case of neuroleukemiosis caused by B cell chronic lymphocytic leukemia, presenting as mononeuritis multiplex.
Vicino A., Cochet S., Pistocchi S., Conrad C., Ribi C., Du Pasquier R., Brouland J.P., Théaudin M., 2023/06. Journal of the peripheral nervous system, 28 (2) pp. 266-268. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0A5312D01C4F]
 
Cytokine storm complicated by cardiogenic shock induced by anti-HER2 therapies.
Godinho R., Noto A., Fenwick C., Stravodimou A., Hugelshofer S., Peters S., Hullin R., Obeid M., 2023/06. Journal for immunotherapy of cancer, 11 (6). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D3B4F544BDF7]
 
Gene Therapy for Inborn Errors of Immunity.
Arlabosse T., Booth C., Candotti F., 2023/06. The journal of allergy and clinical immunology. In practice, 11 (6) pp. 1592-1601. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_74E2CD2A10A2]
Real-life drug retention rate and safety of rituximab when treating rheumatic diseases: a single-centre Swiss retrospective cohort study.
Dumusc A., Alromaih F., Perreau M., Hügle T., Zufferey P., Dan D., 2023/06/01. Arthritis research & therapy, 25 (1) p. 91. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DF31B58270DC]
Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with Cancer.
Liu C., Shatila M., Mathew A., Machado A.P., Thomas A., Zhang H.C., Thomas A.S., Faleck D., Funchain P., Philpott J. et al., 2023/06. Journal of Cancer, 14 (10) pp. 1913-1919. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7A07F987C9FE]
 
Pneumonies communautaires sévères : utilité des corticostéroïdes.
Bart P.A., 2023/05/31. Revue medicale suisse, 19 (829) pp. 1110-1111. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_29599D507B0F]
Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease.
Gatterer C., Beitzke D., Graf S., Lenz M., Sunder-Plassmann G., Mann C., Ponleitner M., Manka R., Fritschi D., Krayenbuehl P.A. et al., 2023/05/19. Life, 13 (5) p. 1213. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_755681B65A74]
Severe combined immunodeficiency: improved survival leading to detection of underlying liver disease.
Vittal A., Abdul Majeed N., Garabedian E., Marko J., Kleiner D.E., Sokolic R., Candotti F., Malech H., Heller T., Koh C., 2023/05/19. BMC gastroenterology, 23 (1) p. 166. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5F4596E72743]
 
ITGAM rs1143679 Variant in Systemic Lupus Erythematosus Is Associated with Increased Serum Calcification Propensity.
Halfon M., Zhang L., Ehirchiou D., Pandian V.D., Dahdal S., Huynh-Do U., Pasch A., Ribi C., Busso N., 2023/05/18. Genes, 14 (5) p. 1105. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B144EDB59ADF]
 
Vaccins contre le RSV: nouveaux arrivants – après SARS-CoV-2 – sur la scène des vaccins.
Bart P.A., 2023/05/10. Revue medicale suisse, 19 (826) p. 923. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_44E440056731]
AKT activity orchestrates marginal zone B cell development in mice and humans.
Cox E.M., El-Behi M., Ries S., Vogt J.F., Kohlhaas V., Michna T., Manfroi B., Al-Maarri M., Wanke F., Tirosh B. et al., 2023/04/25. Cell reports, 42 (4) p. 112378. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_07D42F1D9F07]
Association of plasma zinc levels with anti-SARS-CoV-2 IgG and IgA seropositivity in the general population: A case-control study.
Equey A., Berger M.M., Gonseth-Nusslé S., Augsburger M., Rezzi S., Hodgson ACC, Estoppey S., Pantaleo G., Pellaton C., Perrais M. et al., 2023/04/18. Clinical nutrition, 42 (6) pp. 972-986. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BEE6C76A8AC7]
Remodelling family medicine teaching at the University of Lausanne using a modified Delphi method.
Pedrazzini B., Boulet M.C., Héritier F., Bart P.A., Senn N., 2023/04/17. Swiss medical weekly, 153 (4) p. 40064. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6EB84AD82053]
 
Granulomatose avec polyangéite : quoi de neuf ? [Granulomatosis with polyangiitis: what's new?]
Ringwald M., Chevalley D., Bongard C., Kissling S., Rotman S., Von Garnier C., Ribi C., Comte D., 2023/04/05. Revue medicale suisse, 19 (821) pp. 674-679. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D369BEFFD011]
 
Hypersensibilité aux venins d’hyménoptères : le point en 2023 [Hymenoptera venom allergy: what's new in 2023]
Belkoniene M., Ringwald M., Leimgruber A., Muller Y.D., 2023/04/05. Revue medicale suisse, 19 (821) pp. 663-667. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_53B0B7C3150B]
 
La concision est l’âme de l’esprit.
Seebach J.D., Ribi C., 2023/04/05. Revue medicale suisse, 19 (821) pp. 655-656. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_43703F2D61EC]
 
Maladie des anticorps anti-membrane basale glomérulaire [Anti-glomerular basement membrane disease]
Stevanin M., Kissling S., Daccord C., Rotman S., Comte D., Ribi C., 2023/04/05. Revue medicale suisse, 19 (821) pp. 680-685. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_89863117120D]
Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccines.
Stehlin F., Tommasini F., Monzambani-Banderet V., Girard C., Yerly D., Ribi C., Muller Y.D., 2023/04. Allergology international, 72 (2) pp. 332-334. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F1AE52F9BF9D]
 
O.18.2 - How different dimensions of medical students’ empathy relate to mental health and burnout: Presenter(s): Alexandre Berney, Lausanne University Hospital (CHUV) and University of Lausanne, Switzerland; Sylvie Berney, Lausanne University Hospital (CHUV) and University of Lausanne, Switzerland
Carrard Valerie, Schlegel Katja, Gauma Jacques, Bart Pierre-Alexandre, Preisig Martin, Schmid Mast Marianne, Bourquin Céline, 2023/04/01. Patient Education and Counseling. Peer-reviewed.
[serval:BIB_51A34757A3D1]
 
Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1.
Balakrishna S., Loosli T., Zaheri M., Frischknecht P., Huber M., Kusejko K., Yerly S., Leuzinger K., Perreau M., Ramette A. et al., 2023/03/02. The Journal of antimicrobial chemotherapy, 78 (3) pp. 656-664. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_213147216CE3]
 
Access to gene therapy for rare diseases when commercialization is not fit for purpose.
Fox T., Bueren J., Candotti F., Fischer A., Aiuti A., Lankester A., AGORA Initiative, Booth C., 2023/03. Nature medicine, 29 (3) pp. 518-519. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E19E38D216AF]
 
Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell development.
Scherer S., Oberle S.G., Kanev K., Gerullis A.K., Wu M., de Almeida G.P., Puleston D.J., Baixauli F., Aly L., Greco A. et al., 2023/03. Nature immunology, 24 (3) pp. 501-515. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_37BBC13C5B60]
 
What Is New in Pulmonary Mucormycosis?
Danion F., Coste A., Le Hyaric C., Melenotte C., Lamoth F., Calandra T., Garcia-Hermoso D., Aimanianda V., Lanternier F., Lortholary O., 2023/02/28. Journal of fungi, 9 (3) p. 307. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FC89D4B5FCED]
 
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults.
Cohen K.W., Fiore-Gartland A., Walsh S.R., Yusim K., Frahm N., Elizaga M.L., Maenza J., Scott H., Mayer K.H., Goepfert P.A. et al., 2023/02/15. The Journal of clinical investigation, 133 (4) pp. e163338. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4401BE6482F7]
 
Quantifying and Predicting Ongoing Human Immunodeficiency Virus Type 1 Transmission Dynamics in Switzerland Using a Distance-Based Clustering Approach.
Labarile M., Loosli T., Zeeb M., Kusejko K., Huber M., Hirsch H.H., Perreau M., Ramette A., Yerly S., Cavassini M. et al., 2023/02/14. The Journal of infectious diseases, 227 (4) pp. 554-564. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AAE8A3C815DF]
 
Incidence of Chronic Spontaneous Urticaria Following Receipt of the COVID-19 Vaccine Booster in Switzerland.
Duperrex O., Tommasini F., Muller Y.D., 2023/02/01. JAMA network open, 6 (2) pp. e2254298. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E4E084F2628B]
 
"Inborn errors of immunity: An expanding horizon through a multitude of biological pathways".
Candotti F., Eigenmann P., 2023/01. Pediatric allergy and immunology, 34 (1) pp. e13908. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1E194F423ED2]
A CD64/FcγRI-mediated mechanism hijacks PD-1 from PD-L1/2 interaction and enhances anti-PD-1 functional recovery of exhausted T cells.
Joo V., Petrovas C., de Leval L., Noto A., Obeid M., Fenwick C., Pantaleo G., 2023. Frontiers in immunology, 14 p. 1213375. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_431B1ABF3E8A]
 
Brain Cortical Thickness Predicts Outcomes in Alzheimer’s Disease.
Chén Oliver Y. et al., 2023..
[serval:BIB_088C64508490]
Case report: First-in-human combined low-dose whole-heart irradiation and high-dose stereotactic arrhythmia radioablation for immunosuppressive refractory cardiac sarcoidosis and ventricular tachycardia.
van der Ree M.H., Herrera Siklody C., Le Bloa M., Pascale P., Porretta A.P., Teres C.C., Solana Munoz J., Luca A., Domenichini G., Ozasahin M. et al., 2023. Frontiers in cardiovascular medicine, 10 p. 1213165. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FA14CF085E93]
Differential Production of Midkine and Pleiotrophin by Innate APCs upon Stimulation through Nucleic Acid-Sensing TLRs.
Said E.A., Al-Dughaishi S., Al-Hatmi W., Al-Reesi I., Al-Balushi M.S., Al-Bimani A., Al-Busaidi J.Z., Al-Riyami M., Al-Khabori M., Al-Kindi S. et al., 2023. Journal of immunology research, 2023 p. 7944102. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_708E1F22F737]
Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study.
de Rougemont O., Deng Y., Frischknecht L., Wehmeier C., Villard J., Ferrari-Lacraz S., Golshayan D., Gannagé M., Binet I., Wirthmueller U. et al., 2023. Frontiers in immunology, 14 p. 1104371. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9C3FDBD902B3]
Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation.
Ballou C., Barton F., Payne E.H., Berney T., Villard J., Meier RPH, Baidal D., Alejandro R., Robien M., Eggerman T.L. et al., 2023. Frontiers in immunology, 14 p. 1110544. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_04D10C842266]
 
Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein.
Perdiguero B., Hauser A., Gómez C.E., Peterhoff D., Sideris E., Sorzano CÓS, Wilmschen S., Schaber M., Stengel L., Asbach B. et al., 2023. Frontiers in immunology, 14 p. 1270908. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D789F3FAEA8A]
 
Regulatory T cell homeostasis: Requisite signals and implications for clinical development of biologics.
Skartsis N., Muller Y.D., Ferreira LMR, 2023/01. Clinical immunology, 246 p. 109201. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_460C30B477F0]
Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial.
Stalder G., Suffiotti M., Segot A., Noto A., Pantaleo G., Spertini O., Obeid M., 2023/01/01. Haematologica, 108 (1) pp. 234-239. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5551F9C73188]
SARS-CoV-2 neutralizing antibody response in vaccinated and non-vaccinated hospital healthcare workers with or without history of infection.
Jacot D., von Rotz U., Pellaton C., Blondet F., Aebischer O., Perreau M., De Rham M., Pantaleo G., Marchetti O., Greub G., 2023. Microbes and infection, 25 (1-2) p. 105077. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_35EA6DCB0511]
2022
A differential process mining analysis of COVID-19 management for cancer patients.
Cuendet M.A., Gatta R., Wicky A., Gerard C.L., Dalla-Vale M., Tavazzi E., Michielin G., Delyon J., Ferahta N., Cesbron J. et al., 2022/12/07. Frontiers in oncology, 12 p. 1043675. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_98AD494947E5]
 
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Haanen J., Obeid M., Spain L., Carbonnel F., Wang Y., Robert C., Lyon A.R., Wick W., Kostine M., Peters S. et al., 2022/12. Annals of oncology, 33 (12) pp. 1217-1238. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F3804F73BCD6]
 
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study.
Bettiol A., Urban M.L., Bello F., Fiori D., Mattioli I., Lopalco G., Iannone F., Egan A., Dagna L., Caminati M. et al., 2022/12. Annals of the rheumatic diseases, 81 (12) pp. 1769-1772. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3882E44472F2]
The relationship between medical students' empathy, mental health, and burnout: A cross-sectional study.
Carrard V., Bourquin C., Berney S., Schlegel K., Gaume J., Bart P.A., Preisig M., Schmid Mast M., Berney A., 2022/12. Medical teacher, 44 (12) pp. 1392-1399. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_601B999D0EBE]
CXCL12 and CXCL13 Cytokine Serum Levels Are Associated with the Magnitude and the Quality of SARS-CoV-2 Humoral Responses.
Noto A., Joo V., Mancarella A., Suffiotti M., Pellaton C., Fenwick C., Perreau M., Pantaleo G., 2022/11/28. Viruses, 14 (12) p. 2665. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1C95F51CD2B0]
 
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.
Zanatta E., Huscher D., Ortolan A., Avouac J., Airò P., Balbir-Gurman A., Siegert E., Matucci Cerinic M., Cozzi F., Riemekasten G. et al., 2022/11/28. Rheumatology, 61 (12) pp. 4786-4796. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3C34847ADF34]
Host Molecule Incorporation into HIV Virions, Potential Influences in HIV Pathogenesis.
Munoz O., Banga R., Perreau M., 2022/11/14. Viruses, 14 (11). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E603E7404562]
 
Rapid onset of chronic urticaria after Moderna COVID-19 booster vaccine
Olivier Duperrex, Francesco Tommasini, Yannick Muller, 2022/11/04..
[DOI][serval:BIB_E54D8CF6479E]
 
Clinical and immunological data from chronic urticaria onset after mRNA SARS-CoV-2 vaccines.
Pescosolido E., Muller Y.D., Sabaté-Brescó M., Ferrer M., Yerly D., Caubet J.C., Lantin J.P., Ribi C., Bergmann M.M., 2022/11. Clinical and experimental allergy, 52 (11) pp. 1343-1346. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_75DE4F933D73]
Inhibiteurs des Janus kinases : nouvelles perspectives pour la médecine de précision ? [Janus kinase inhibitors : new perspectives for precision medicine ?]
Tachet J., Dumusc A., Conrad C., Grandoni F., Chalandon Y., Ribi C., Buclin T., Girardin F., 2022/10/19. Revue medicale suisse, 18 (800) pp. 1979-1983. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0D12F79D0C49]
 
Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
Hashem H., Bucciol G., Ozen S., Unal S., Bozkaya I.O., Akarsu N., Taskinen M., Koskenvuo M., Saarela J., Dimitrova D. et al., 2022/10..
[DOI][WoS][Pmid][serval:BIB_158647440B8D]
COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctions.
Schrijver I.T., Théroude C., Antonakos N., Regina J., Le Roy D., Bart P.A., Chiche J.D., Perreau M., Pantaleo G., Calandra T. et al., 2022/10. European journal of immunology, 52 (10) pp. 1676-1679. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CE51282F926C]
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events.
Coukos A., Vionnet J., Obeid M., Bouchaab H., Peters S., Latifyan S., Wicky A., Michielin O., Chtioui H., Moradpour D. et al., 2022/10. Journal for immunotherapy of cancer, 10 (10) pp. e005635. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F836C2B098EA]
 
A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort Study.
Chaudron S.E., Leemann C., Kusejko K., Nguyen H., Tschumi N., Marzel A., Huber M., Böni J., Perreau M., Klimkait T. et al., 2022/09/28. The Journal of infectious diseases, 226 (7) pp. 1256-1266. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F747BBEF0F8F]
Generation of transgene-free human induced pluripotent stem cells from erythroblasts in feeder-free conditions.
Perriot S., Canales M., Mathias A., Du Pasquier R., 2022/09/16. STAR protocols, 3 (3) p. 101620. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8C8118CBC867]
Different classes of genomic inserts contribute to human antibody diversity.
Lebedin M., Foglierini M., Khorkova S., Vázquez García C., Ratswohl C., Davydov A.N., Turchaninova M.A., Daubenberger C., Chudakov D.M., Lanzavecchia A. et al., 2022/09/06. Proceedings of the National Academy of Sciences of the United States of America, 119 (36) pp. e2205470119. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7CD7BE178493]
Antibodies to combat viral infections: development strategies and progress.
Pantaleo G., Correia B., Fenwick C., Joo V.S., Perez L., 2022/09. Nature reviews. Drug discovery, 21 (9) pp. 676-696. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_09F440C68729]
 
Editorial comment on "Inborn errors of immunity associated with defects of thymic development".
Beken B., Castagnoli R., Candotti F., 2022/09. Pediatric allergy and immunology, 33 (9) pp. e13847. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EEF54F454139]
Long-term outcomes in corticosteroid-refractory Graves' orbitopathy treated with tocilizumab.
Moi L., Hamedani M., Ribi C., 2022/09. Clinical endocrinology, 97 (3) pp. 363-370. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EAD5932101A4]
Magnitude and associated factors of latent tuberculosis infection due to Mycobacterium tuberculosis complex among high-risk groups in urban Bobo-Dioulasso, Burkina Faso.
Djibougou D.A., Mensah G.I., Sagna T., Sawadogo L.T., Ouedraogo A.K., Kabore A., Hien H., Meda C.Z., Combary A., Belem A.M. et al., 2022/09. IJID regions, 4 pp. 1-9. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_66E3C334DF46]
 
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys.
Fenwick C., Turelli P., Ni D., Perez L., Lau K., Herate C., Marlin R., Lana E., Pellaton C., Raclot C. et al., 2022/09. Nature microbiology, 7 (9) pp. 1376-1389. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_539E1A543541]
Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort.
Menges D., Zens K.D., Ballouz T., Caduff N., Llanas-Cornejo D., Aschmann H.E., Domenghino A., Pellaton C., Perreau M., Fenwick C. et al., 2022/08/18. Nature communications, 13 (1) p. 4855. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F6D33AB61943]
A Phylogeny-aware GWAS Framework to Correct for Heritable Pathogen Effects on Infectious Disease Traits.
Nadeau S., Thorball C.W., Kouyos R., Günthard H.F., Böni J., Yerly S., Perreau M., Klimkait T., Rauch A., Hirsch H.H. et al., 2022/08/03. Molecular biology and evolution, 39 (8) pp. msac163. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C0A2EB45D9AE]
Functional immunity against SARS-CoV-2 in the general population after a booster campaign and the Delta and Omicron waves, Switzerland, March 2022.
Amati R., Frei A., Kaufmann M., Sabatini S., Pellaton C., Fehr J., Albanese E., Puhan M.A., Corona Immunitas Research Group, 2022/08. Euro surveillance, 27 (31). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6DDFE21CA95A]
 
SARS-CoV-2 seroprevalence in hospital healthcare workers in Western Switzerland at the end of the second pandemic wave.
Jacot D., von Rotz U., Blondet F., Aebischer O., Matthieu P., De Rham M., Pantaleo G., Marchetti O., Greub G., 2022/08. Journal of medical microbiology, 71 (8). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2E339D4530BF]
Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 Epidemics.
Kusejko K., Tschumi N., Chaudron S.E., Nguyen H., Battegay M., Bernasconi E., Böni J., Huber M., Calmy A., Cavassini M. et al., 2022/08/01. Journal of acquired immune deficiency syndromes, 90 (4) pp. e4-e12. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6FD8C532081B]
 
Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group.
Nguyen H., Hampel B., Nuñez D.G., Battegay M., Hachfeld A., Bernasconi E., Calmy A., Cavassini M., Vernazza P., Fellay J. et al., 2022/07/06. Clinical infectious diseases, 74 (12) p. 2266. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7D8CAA9F6BAD]
Active PD-L1 incorporation within HIV virions functionally impairs T follicular helper cells.
Munoz O., Banga R., Schelling R., Procopio F.A., Mastrangelo A., Nortier P., Ohmiti K., Daraspe J., Cavassini M., Fenwick C. et al., 2022/07. PLoS pathogens, 18 (7) pp. e1010673. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BEB839579791]
 
Common Variable Immunodeficiency in a Carrier of the ADA2 R169Q Variant: Coincidence or Causality?
Moi L., Schnider C., Riccio O., Hershfield M.S., Candotti F., 2022/07. Journal of clinical immunology, 42 (5) pp. 959-961. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CB464CB7181B]
Measurement of circulating CD21-CD27- B lymphocytes in SLE patients is associated with disease activity independently of conventional serological biomarkers.
Horisberger A., Humbel M., Fluder N., Bellanger F., Fenwick C., Ribi C., Comte D., 2022/06/02. Scientific reports, 12 (1) p. 9189. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_79225BAA39D6]
 
Serum interferon-α levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity.
Chasset F., Mathian A., Dorgham K., Ribi C., Trendelenburg M., Huynh-Do U., Roux-Lombard P., Courvoisier D.S., Amoura Z., Gorochov G. et al., 2022/06. Annals of the rheumatic diseases, 81 (6) pp. 901-903. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F017A3490498]
Multifocal lymphadenopathies with polyclonal reactions primed after EBV infection in a mRNA-1273 vaccine recipient.
Girardin F.R., Tzankov A., Pantaleo G., Livio F., Greub G., 2022/05/23. Swiss medical weekly, 152 pp. w30188. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_378A2D414165]
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19.
Kritikos A., Gabellon S., Pagani J.L., Monti M., Bochud P.Y., Manuel O., Coste A., Greub G., Perreau M., Pantaleo G. et al., 2022/05/18. Viruses, 14 (5) p. 1089. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7AA364497D07]
 
Behçet's-like adverse event or inaugural Behçet's disease after SARS-CoV-2 mRNA-1273 vaccination?
Tagini F., Carrel L., Fallet B., Gachoud D., Ribi C., Monti M., 2022/05/05. Rheumatology, 61 (5) pp. e112-e113. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6E6FC4FFA465]
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients.
Obeid M., Suffiotti M., Pellaton C., Bouchaab H., Cairoli A., Salvadé V., Stevenel C., Hottinger R., Pythoud C., Coutechier L. et al., 2022/05/01. JAMA oncology, 8 (5) pp. e220446. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8956034C5615]
Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period.
Lazor-Blanchet C., Zygoura P., Dafni U., Lamoth F., Tsourti Z., Lobritz M.A., Regina J., Grandbastien B., Fenwick C., Pantaleo G. et al., 2022/05. The Journal of infection, 84 (5) pp. 722-746. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AB5408AF350D]
 
Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group.
Nguyen H., Hampel B., Garcia Nuñez D., Battegay M., Hachfeld A., Bernasconi E., Calmy A., Cavassini M., Vernazza P., Fellay J. et al., 2022/04/28. Clinical infectious diseases, 74 (8) pp. 1468-1475. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_966C936A2B27]
T cell receptor and IL-2 signaling strength control memory CD8<sup>+</sup> T cell functional fitness via chromatin remodeling.
Chin S.S., Guillen E., Chorro L., Achar S., Ng K., Oberle S., Alfei F., Zehn D., Altan-Bonnet G., Delahaye F. et al., 2022/04/26. Nature communications, 13 (1) p. 2240. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1F1F88D878BE]
Déficit en adénosine désaminase 2 : une maladie aux présentations multiples [Adenosine deaminase 2 deficiency: a disease with multiple presentations]
Caratsch L., Schnider C., Moi L., Theodoropoulou K., Candotti F., Hofer M., 2022/04/06. Revue medicale suisse, 18 (776) pp. 669-673. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D3726C7A7818]
Maladies causées par Anisakis simplex chez l’humain [Human diseases caused by Anisakis simplex]
Ringwald M., Muller Y.D., Ribi C., 2022/04/06. Revue medicale suisse, 18 (776) pp. 634-638.
[URN][DOI][Pmid][serval:BIB_C100DD2F9489]
Réactions d’hypersensibilité au fer intraveineux : le point de vue de l’allergologue [Hypersensitivity reactions to intravenous iron: an allergist' perspective]
Moi L., Stehlin F., Desseauve D., Ribi C., Muller Y.D., 2022/04/06. Revue medicale suisse, 18 (776) pp. 639-645. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_549B88D4BEB5]
High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus.
Herderschee J., Heinonen T., Fenwick C., Schrijver I.T., Ohmiti K., Moradpour D., Cavassini M., Pantaleo G., Roger T., Calandra T. et al., 2022/04. Clinical microbiology and infection, 28 (4) pp. 611.e1-611.e7. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_300AF1BADC64]
 
Procalcitonina es superior a recuento linfocitario, índice neutrófilo/linfocito y proteína C reactiva para la predicción de mortalidad a 30 días de pacientes con COVID-19 en el servicio de urgencias = Procalcitonin concentration in the emergency department predicts 30-day mortality in COVID-19 better than the lymphocyte count, the neutrophil-tolymphocyte ratio, or the C-reactive protein level.
López-Ayala P., Alcaraz-Serna A., Valls Carbó A., Cuadrado Cenzual M.Á., Torrejón Martínez M.J., López Picado A., Martínez Valero C., Miranda J.D., Díaz Del Arco C., Cozar López G. et al., 2022/04. Emergencias, 34 (2) pp. 119-127. Peer-reviewed.
[WoS][Pmid][serval:BIB_74504AC9E2AD]
 
Signaling networks in B cell development and related therapeutic strategies.
Ren A., Sun J., Yin W., Westerberg L.S., Miller H., Lee P., Candotti F., Guan F., Lei J., Gong Q. et al., 2022/04. Journal of leukocyte biology, 111 (4) pp. 877-891. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B8683F218609]
Structural basis for HCMV Pentamer receptor recognition and antibody neutralization.
Kschonsak M., Johnson M.C., Schelling R., Green E.M., Rougé L., Ho H., Patel N., Kilic C., Kraft E., Arthur C.P. et al., 2022/03/11. Science advances, 8 (10) pp. eabm2536. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9AD2F453F4AF]
Critical role of WASp in germinal center tolerance through regulation of B cell apoptosis and diversification.
Descatoire M., Fritzen R., Rotman S., Kuntzelman G., Leber X.C., Droz-Georget S., Thrasher A.J., Traggiai E., Candotti F., 2022/03/08. Cell reports, 38 (10) p. 110474. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_114B7364DECA]
Non-immediate drug hypersensitivity reactions secondary to intravitreal anti-vascular endothelial growth factors.
Moret E., Ambresin A., Gianniou C., Bijon J., Besse-Hayat C., Bogiatzi S., Hohl D., Spertini F., Mantel I., 2022/03. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 260 (3) pp. 1005-1014. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C16845CB364E]
 
SARS-CoV-2 Omicron potently neutralized by a novel antibody with unique Spike binding properties
Fenwick Craig, Turelli Priscilla, Ni Dongchun, Perez Laurent, Lau Kelvin, Lana Erica, Pellaton Céline, Raclot Charlène, Esteves-Leuenberger Line, Campos Jérémy et al., 2022/03..
[DOI][serval:BIB_938CCD54F9CA]
 
Cohort Profile Update: The Swiss HIV Cohort Study (SHCS).
Scherrer A.U., Traytel A., Braun D.L., Calmy A., Battegay M., Cavassini M., Furrer H., Schmid P., Bernasconi E., Stoeckle M. et al., 2022/02/18. International journal of epidemiology, 51 (1) pp. 33-34j. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CAE07421BB63]
Detecting Selection in the HIV-1 Genome during Sexual Transmission Events.
Seifert D., Joos B., Braun D.L., Oberle C.S., Schenkel C.D., Kuster H., Grube C., Böni J., Yerly S., Aubert V. et al., 2022/02/16. Viruses, 14 (2) p. 406. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0B43AB7DD662]
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study.
Bettiol A., Urban M.L., Dagna L., Cottin V., Franceschini F., Del Giacco S., Schiavon F., Neumann T., Lopalco G., Novikov P. et al., 2022/02. Arthritis & rheumatology, 74 (2) pp. 295-306. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_01372D0A9355]
Allergologie-immunologie - Maladies autoimmunes complexes : quand les glucocorticoïdes ne suffisent plus [Difficult to treat auto-immune diseases : when glucocorticoids are not enough]
Dereme J., Belkoniene M., Ribi C., 2022/01/19. Revue medicale suisse, 18 (764-5) pp. 15-17. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_AECB3687D942]
 
Increasing Frequency and Transmission of HIV-1 Non-B Subtypes Among Men Who Have Sex With Men in the Swiss HIV Cohort Study.
Duran Ramirez J.J., Ballouz T., Nguyen H., Kusejko K., Chaudron S.E., Huber M., Hirsch H.H., Perreau M., Ramette A., Yerly S. et al., 2022/01/18. The Journal of infectious diseases, 225 (2) pp. 306-316. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A7E78283DB80]
Has the profile of heart transplantation recipients changed within the last three decades?
Anouck Z., Tozzi P., Regamey J., Abdurashidova T., Meyer P., Lefol K., Pascual M., Yerly P., Aubert V., Aur S. et al., 2022/01/17. Swiss medical weekly, 152 pp. w30108. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_31EADDEE19EC]
Sarcoidosis - a multisystem disease.
Franzen D.P., Brutsche M., Nilsson J., Böni C., Daccord C., Distler O., Elsener D., Funke-Chambour M., Gruner C., Hayward-Könnecke H. et al., 2022/01/03. Swiss medical weekly, 152 pp. w30049. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BE7643C6051D]
Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activity.
Nowak A., Dormond O., Monzambani V., Huynh-Do U., Barbey F., 2022. Molecular genetics and metabolism, 137 (1-2) pp. 173-178. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_66790C835243]
Atopy as an independent predictor for long-term patient and graft survival after kidney transplantation.
Porret R., Meier RPH, Mikulic J., Pascual M., Aubert V., Harr T., Golshayan D., Muller Y.D., 2022. Frontiers in immunology, 13 p. 997364. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3741B3D0D5D4]
B cell-T cell interplay in immune regulation: A focus on follicular regulatory T and regulatory B cell functions.
Tan D., Yin W., Guan F., Zeng W., Lee P., Candotti F., James L.K., Saraiva Camara N.O., Haeryfar SMM, Chen Y. et al., 2022. Frontiers in cell and developmental biology, 10 p. 991840. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C05812F2D567]
Case Report: Susceptibility to viral infections and secondary hemophagocytic lymphohistiocytosis responsive to intravenous immunoglobulin as primary manifestations of adenosine deaminase 2 deficiency.
Drago E., Garbarino F., Signa S., Grossi A., Schena F., Penco F., Santori E., Candotti F., Boztug K., Volpi S. et al., 2022. Frontiers in immunology, 13 p. 937108. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E9D9D3B88DB9]
Complement blockade with eculizumab to treat acute symptomatic humoral rejection after heart transplantation.
Yerly P., Rotman S., Regamey J., Aubert V., Aur S., Kirsch M., Hullin R., Pascual M., 2022/01. Xenotransplantation, 29 (1) pp. e12726. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_81DB4AE7643B]
Human macrophages and monocyte-derived dendritic cells stimulate the proliferation of endothelial cells through midkine production.
Said E.A., Al-Dughaishi S., Al-Hatmi W., Al-Reesi I., Al-Riyami M., Al-Balushi M.S., Al-Bimani A., Al-Busaidi J.Z., Al-Khabori M., Al-Kindi S. et al., 2022. PloS one, 17 (4) pp. e0267662. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_31DADE94BC9B]
Iberogast®-Induced Acute Liver Injury—A Case Report
Leroy A., Perrin H., Porret R., Sempoux C., Chtioui H., Fraga M., Bart PA, 2022. Gastro Hep Advances, 1 (4) pp. 601-603.
[URN][DOI][serval:BIB_5E2F0FB82317]
Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance.
Stehlin F., Mahdi-Aljedani R., Canton L., Monzambani-Banderet V., Miauton A., Girard C., Kammermann K., Meylan S., Ribi C., Harr T. et al., 2022. Frontiers in allergy, 3 p. 818049. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_308D5854A6E6]
 
Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients.
Wiedemann A., Pellaton C., Dekeyser M., Guillaumat L., Déchenaud M., Krief C., Lacabaratz C., Grimbert P., Pantaleo G., Lévy Y. et al., 2022. Frontiers in medicine, 9 p. 978764. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3A74857F7FD8]
Management of Beta-Lactam Antibiotics Allergy: A Real-Life Study.
Iuliano S., Senn L., Moi L., Muller Y.D., Ribi C., Buss G., Comte D., 2022. Frontiers in allergy, 3 p. 853587. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_6BA45BE8BAD0]
 
Racisme et pratique de la médecine : éléments pour un apprentissage nécessaire
Bodenmann Patrick, Hrasnica Farah, Prod'hom Dimitri, Perrin Ève Marie, Ishii Alessandro, Porret Raphaël, Fricker Cédric, Morisod Kevin, Sanchis Zozaya Javier, Malebranche Mary et al., 2022. pp. 165-177 dans Bodenmann Patrick, Jackson Yves, Vu Francis, Wolff Hans (eds.) Vulnérabilités, diversités et équité en santé chap. 1.14, RMS éditions / Médecine et Hygiène.
[serval:BIB_140A6A81D8C8]
SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus.
Humbel M., Bellanger F., Horisberger A., Suffiotti M., Fluder N., Makhmutova M., Mathias A., Du Pasquier R., Fenwick C., Ribi C. et al., 2022. Frontiers in immunology, 13 p. 843059. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_439FE028F29F]
Syndrome post-Covid-19 et maladies autoimmunes : un parallèle ?
Ribi Camillo, Seebach Jörg D., 2022. Revue Médicale Suisse, 18 (776) pp. 631-632. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0B3CC4A933A4]
The deficiency in Th2-like Tfh cells affects the maturation and quality of HIV-specific B cell response in viremic infection.
Noto A., Suffiotti M., Joo V., Mancarella A., Procopio F.A., Cavet G., Leung Y., Corpataux J.M., Cavassini M., Riva A. et al., 2022. Frontiers in immunology, 13 p. 960120. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3A9147719CB5]
The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation - Data from the Swiss transplant cohort study.
Frischknecht L., Deng Y., Wehmeier C., de Rougemont O., Villard J., Ferrari-Lacraz S., Golshayan D., Gannagé M., Binet I., Wirthmueller U. et al., 2022. Frontiers in immunology, 13 p. 1005790. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BD83D5777603]
The role of B cells in COVID-19 infection and vaccination.
Chen S., Guan F., Candotti F., Benlagha K., Camara NOS, Herrada A.A., James L.K., Lei J., Miller H., Kubo M. et al., 2022. Frontiers in immunology, 13 p. 988536. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_29D06720D861]
 
TILDA: Tat/Rev Induced Limiting Dilution Assay
Lungu Cynthia, Procopio Francesco A., 2022. pp. 365-372 dans HIV Reservoirs, Springer US.
[DOI][Pmid][serval:BIB_02AF14815078]
Underuse of Epinephrine for the Treatment of Anaphylaxis in the Prehospital Setting.
Dami F., Enggist R., Comte D., Pasquier M., 2022. Emergency medicine international, 2022 p. 5752970. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9AD9097E882F]
 
Xenotransplantation: A New Era.
Carrier A.N., Verma A., Mohiuddin M., Pascual M., Muller Y.D., Longchamp A., Bhati C., Buhler L.H., Maluf D.G., Meier RPH, 2022. Frontiers in immunology, 13 p. 900594. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_967E8862A91F]
2021
Characterizing cytomegalovirus infection one cell at a time.
Perez L., 2021/12. Nature microbiology, 6 (12) pp. 1477-1478. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3F64045630BA]
 
Large-scale screening is not useful for identifying individuals with hepatitis B or C virus infection: A prospective Swiss study.
Djebali-Trabelsi A., Marot A., André C., Deltenre P., 2021/12. Journal of viral hepatitis, 28 (12) pp. 1756-1758. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_894D4FE26DFE]
 
Pre-transplant donor-specific HLA antibodies and risk for poor first-year renal transplant outcomes: results from the Swiss Transplant Cohort Study.
Wehmeier C., Amico P., Sidler D., Wirthmüller U., Hadaya K., Ferrari-Lacraz S., Golshayan D., Aubert V., Schnyder A., Sunic K. et al., 2021/12. Transplant international, 34 (12) pp. 2755-2768. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AD21EC0FD8B7]
Prevalence of large vessel vasculitis in ANCA-associated vasculitis: a retrospective cohort study.
Coattrenec Y., Muller Y.D., Spoerl D., Lobrinus J.A., Seebach J.D., 2021/12. Rheumatology international, 41 (12) pp. 2147-2156.
[URN][DOI][WoS][Pmid][serval:BIB_EE2BF9BF9379]
Approche diagnostique et thérapeutique d’un asthme difficile [Diagnostic and therapeutic approach to difficult asthma]
Grandbastien M., Kolb M., Ribi C., Von Garnier C., 2021/11/17. Revue medicale suisse, 17 (759) pp. 1979-1983. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F2E0947D9B17]
Vaccins à ARN messager contre le Covid-19 : piqûre de rappel [mRNA Covid vaccines: What do we know eight months after deployment]
Miauton A., Besson J., Muller Y., Genton B., 2021/11/10. Revue medicale suisse, 17 (758) pp. 1910-1914. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_CE2F5557994E]
 
Un sepsis qui laisse sceptique
Cisarovsky Christophe, Gautier Maxime, Ribi Camillo, Kraege Vanessa, Sartori Claudio, 2021/11/09. Forum Médical Suisse ‒ Swiss Medical Forum, 21 (4546) pp. 782-785. Peer-reviewed.
[DOI][serval:BIB_AEC46FCD6E7F]
 
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study.
Zou F., Faleck D., Thomas A., Harris J., Satish D., Wang X., Charabaty A., Ernstoff M.S., Glitza Oliva I.C., Hanauer S. et al., 2021/11. Journal for immunotherapy of cancer, 9 (11) pp. e003277. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D947D0B8BF9D]
 
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials.
Fischinger S., Cizmeci D., Deng D., Grant S.P., Frahm N., McElrath J., Fuchs J., Bart P.A., Pantaleo G., Keefer M. et al., 2021/11. PLoS pathogens, 17 (11) pp. e1010016. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F1241293379B]
When obstetrics-gynecology specialists need to call an ophthalmologist urgently: a case report.
Masmejan S., Guex-Crosier Y., Diserens C., Vouga M., Clottu A.S., Ribi C., Mathevet P., Jacot-Guillarmod M., 2021/10/21. Journal of medical case reports, 15 (1) p. 517. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_167F066D1D77]
 
Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency.
Reinhardt B., Habib O., Shaw K.L., Garabedian E., Carbonaro-Sarracino D.A., Terrazas D., Fernandez B.C., De Oliveira S., Moore T.B., Ikeda A.K. et al., 2021/10/14. Blood, 138 (15) pp. 1304-1316. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EFBE68E0CAAF]
A highly potent antibody effective against SARS-CoV-2 variants of concern.
Fenwick C., Turelli P., Perez L., Pellaton C., Esteves-Leuenberger L., Farina A., Campos J., Lana E., Fiscalini F., Raclot C. et al., 2021/10/12. Cell reports, 37 (2) p. 109814. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6CC56B59453A]
 
Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor-Based Antiretroviral Treatment.
Pyngottu A., Scherrer A.U., Kouyos R., Huber M., Hirsch H., Perreau M., Yerly S., Calmy A., Cavassini M., Stöckle M. et al., 2021/10/05. Clinical infectious diseases, 73 (7) pp. e2134-e2141. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FCC193ED7F6C]
68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis.
Boughdad S., Latifyan S., Fenwick C., Bouchaab H., Suffiotti M., Moslehi J.J., Salem J.E., Schaefer N., Nicod-Lalonde M., Costes J. et al., 2021/10. Journal for immunotherapy of cancer, 9 (10) pp. e003594. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6D88B7F593BA]
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
Hashem H., Bucciol G., Ozen S., Unal S., Bozkaya I.O., Akarsu N., Taskinen M., Koskenvuo M., Saarela J., Dimitrova D. et al., 2021/10. Journal of clinical immunology, 41 (7) pp. 1633-1647. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F136CAD06DF2]
 
Successful Rapid Oral Desensitization to Ibrutinib in a Patient With Severe Immediate Hypersensitivity Reaction.
Tsilimidos G., Horisberger A., Ribi C., Cairoli A., Stalder G., 2021/10. Clinical lymphoma, myeloma & leukemia, 21 (10) pp. e745-e747. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ACE484B254A3]
 
Limited access to antigen drives generation of early B cell memory while restraining the plasmablast response.
Glaros V., Rauschmeier R., Artemov A.V., Reinhardt A., Ols S., Emmanouilidi A., Gustafsson C., You Y., Mirabello C., Björklund Å.K. et al., 2021/09/14. Immunity, 54 (9) pp. 2005-2023.e10. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_35B9E7F5BCE4]
 
High levels of interleukine-6 in ascites prevent ascites reinfusion during hemodialysis.
Halfon M., Artru F., Fraga M., Comte D., Alberio L., Brunet J.F., Fakhouri F., Kissling S., 2021/09. Clinics and research in hepatology and gastroenterology, 45 (5) p. 101734. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_286BB643A89B]
Hépatite autoimmune : mise au point 2021 [Autoimmune hepatitis: 2021 update]
Stamm G.M., Sempoux C., Fraga M., Comte D., Aubert V., Moradpour D., Vionnet J., Moschouri E., 2021/09/01. Revue medicale suisse, 17 (748) pp. 1457-1463. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E7CF6654AD62]
 
Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study.
Meier A.L., Bodmer N.S., Wirth C., Bachmann L.M., Ribi C., Pröbstel A.K., Waeber D., Jelcic I., Steiner U.C., Swiss SLE Cohort Study (SSCS), 2021/09. Lupus, 30 (10) pp. 1565-1576. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_28293ADE1035]
 
Reactivation of IgA vasculitis after COVID-19 vaccination.
Obeid M., Fenwick C., Pantaleo G., 2021/09. The Lancet. Rheumatology, 3 (9) pp. e617. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1D8F6DD0B85B]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University